What is the primary reason for treating hyperlipidemia?

Treating hyperlipidemia primarily focuses on preventing coronary artery disease (CAD) and its associated complications. Elevated levels of lipids, especially low-density lipoprotein (LDL) cholesterol, are major risk factors for the development of atherosclerosis, which can lead to CAD. By managing and lowering lipid levels, healthcare providers aim to decrease the incidence of cardiovascular events such as heart attacks and strokes.

Key components in the management of hyperlipidemia involve lifestyle modifications, such as diet and exercise, and pharmacologic interventions like statins, which are effective in reducing LDL cholesterol levels. Although increasing HDL cholesterol and lowering triglycerides can be beneficial and part of overall lipid management, they are secondary to the chief aim of reducing the risk of CAD. Improving liver function is not a typical goal of hyperlipidemia treatment and is more relevant in contexts like liver disease rather than cardiovascular risk management. Therefore, the primary goal remains in preventing CAD through effective lipid control.